Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02120703
Other study ID # 173-SUR-ERC-10
Secondary ID
Status Completed
Phase Phase 3
First received April 19, 2014
Last updated April 22, 2014
Start date February 2011
Est. completion date October 2011

Study information

Verified date April 2014
Source Aga Khan University
Contact n/a
Is FDA regulated No
Health authority Pakistan: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

Pregabalin is claimed to have superior analgesic effect at lower doses and better pharmacological profile as compared to gabapentin esp. in perioperative pain control after major surgeries like intervertebral disc surgery.

The investigators found that pregabalin is equivalent to gabapentin for relief of post-operative pain at a lower dose in patients undergoing intervertebral disc surgery.


Recruitment information / eligibility

Status Completed
Enrollment 78
Est. completion date October 2011
Est. primary completion date October 2011
Accepts healthy volunteers No
Gender Both
Age group 30 Years to 60 Years
Eligibility Inclusion Criteria:

- 30-60 years age

- Any gender

- elective micro discectomy for intervertebral disc prolapse

Exclusion Criteria:

1. micro discectomy at two or more vertebral levels,

2. Instrumentation i.e. pedicle screw fixation, hooks etc.,

3. history of steroids or alcohol use,

4. Multiple co-morbids i.e. renal failure, chronic liver disease,

5. use of anticonvulsant drugs,

6. Spinal deformity,

7. Obesity (BMI >30), 8) inability to understand and respond VAS and

9) patients with known allergy to GABA analogues.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care


Intervention

Drug:
Pregabalin
Pregablin 75 mg per oral two times a day
Gabapentin
Gabapentin 200 mg twice daily per oral

Locations

Country Name City State
Pakistan The Aga Khan University Hospital Karachi Sind

Sponsors (1)

Lead Sponsor Collaborator
Aga Khan University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain Pain measurement using Visual Analogue Score at 24 hours and 7th day of surgery 7 days No